People · Operator
Named in public records as an officer, director or promoter · active 2014–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Celcuity Inc. | — | Biotechnology | Series D+ | $303.0M | $691.3M | 2014 |
Lance G. Laing at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lance G. Laing on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| RICHARD J. NIGON | 1 | 4 |
| David F. Dalvey | 1 | 1 |
| Vicky G. Hahne | 1 | 1 |
| Richard E. Buller | 1 | 1 |
| Polly A. Murphy | 1 | 1 |
| Leo T. Furcht | 1 | 1 |
| Leo G. Furcht | 1 | 1 |
| Brian F. Sullivan | 1 | 1 |
| Maureen G. Cronin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.